- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
Beyond RFK, Jr., there are a number of individuals in the running to take various health care posts in the upcoming Trump Administration:
https://rollcall.com/2024/11/07/a-look-at-those-who-could-be-on-trumps-health-team-short-list/
A look at those who could be on Trump’s health team short list
RFK Jr., Jindal among those thought to be contenders for key Trump health positions
By Ariel Cohen - November 7, 2024President-elect Donald Trump has pledged to involve anti-vaccine activist and conspiracy theorist Robert F. Kennedy Jr. in his next administration in some capacity, but whoever else he picks to run the major health agencies will have a major impact on the GOP health agenda of the next four years.
Top posts require Senate confirmation, meaning Trump will need Senate buy-in too. Positions include Health and Human Services secretary, which requires Senate confirmation; Centers for Disease Control and Prevention director, which will require Senate confirmation beginning in January 2025; Food and Drug Administration commissioner and National Institutes of Health director, which also require Senate confirmation.
Republican health priorities will likely include increased health care transparency and lowering drug costs, as well as limiting health care access for LGBTQ individuals and, potentially, further limiting access to abortion. This might look like rolling back Title X regulations, which are federal dollars for family planning, or the Mexico City policy, which blocks federal funding for nongovernmental organizations that provide abortion counseling or services.
It could also look like rollbacks of rules regarding nondiscrimination in health care, drug price negotiation interference or nursing home staffing mandates.
Here are some of the names being mentioned for future Trump health policy roles:
Robert F. Kennedy Jr.
Trump reiterated his pledge to involve RFK Jr. in his administration during his victory speech on Tuesday, but it’s unlikely he’ll be nominated to lead a major agency.“He’s going to help make America healthy again. He’s a great guy and he really means it. He wants to do some things, and we’re going to let him go to it,” Trump told supporters at the West Palm Beach Convention Center during his victory speech Tuesday night.
In an MSNBC interview on Wednesday morning, Kennedy said he would clear out entire departments of the FDA, including the nutrition department, which was recently revamped as part of the agency’s effort to create a Human Foods Program.
Many experts say they imagine Kennedy will serve more as an informal adviser to Trump, because it could be difficult to get a majority of senators, even in a GOP-led chamber, to confirm him.
“I see someone like that a little more in kind of the Elon Musk type of role … somebody who is whispering in the ear of the administration,” said K&L Gates government affairs adviser and former RNC delegate Amy Carnevale.
Joseph A. Ladapo
Florida Surgeon General Joseph Ladapo is under consideration to lead HHS, ABC News first reported.Like Kennedy, Ladapo is a vaccine skeptic.
Under his leadership, Florida skirted CDC pandemic guidelines regarding masks and social distancing, as well as vaccine requirements for children. In October 2022, he recommended that men between ages 18 and 39 avoid the COVID-19 mRNA vaccines because of a slightly increased risk for cardiac-related deaths. The study he referenced was widely criticized, and the FDA and CDC sent him a letter asking him to stop spreading disinformation.
Lapado was first appointed by Republican Gov. Ron DeSantis in 2021.
After Trump’s win, Ladapo tweeted on Wednesday that the “future of health freedom in America looked brighter.”
“Just as in Florida, it’s time to say ‘No’ to trampling on people’s rights, to gaslighting citizens about experimental vaccines that harm instead of help & to muzzling doctors who dissent with orthodoxy. Light triumphs over darkness,” he said.
Roger Severino
Roger Severino, the former director of the HHS Office of Civil Rights under Trump and current vice president of domestic policy at the Heritage Foundation, wrote the HHS portion of Project 2025.Severino is one of the most vocal abortion opponents in the GOP. He has repeatedly said that the government should not treat abortion as health care and calls for reversing approval of medication abortion, codifying the Hyde amendment and removing the morning-after pill from the contraceptive mandate.
In Project 2025 he also encourages the NIH to stop promoting “junk gender science” and redefine the definition of sex so it does not include gender identity, among other things.
Brian Blase
Brian Blase, a former Trump special assistant to the president for economic policy at the White House’s National Economic Council and currently the president of Paragon Health Institute, could come back around for a second administration.In his most recent email blast, Blase called Trump’s victory “an opportunity to build on the health care successes of his first term” — pointing mainly to policies that expanded the availability of short-term health plans, association health plans and price transparency.
During the Biden administration, Blase has been analyzing and promoting the expansion of health savings account plans. He has proposed providing lower-income exchange enrollees the option to receive a portion of their subsidy as a HSA deposit rather than a subsidy to the insurer.
He also argued against the Biden administration’s expansion of Medicaid during the COVID-19 public health emergency, and called for limiting the program’s scope to just the lowest-income and most vulnerable individuals.
Paul Mango
Mango, another former Trump administration official and an adviser at the Paragon Institute, served as HHS deputy chief of staff from 2019 through 2021 and served as HHS Secretary Alex Azar’s formal liaison to Operation Warp Speed. From 2018 to 2019, Mango served as chief of staff for the Centers for Medicare and Medicaid Services. His institutional knowledge of the department could be seen as an asset to an incoming Trump administration.Eric Hargan
Another Trump administration alumni, Eric Hargan served as deputy HHS secretary under Trump and also as acting secretary. He also served on the board of Operation Warp Speed. Hargan oversaw the setup and launch of the pandemic-era Provider Relief Fund.Hargan was also acting HHS deputy secretary under then-President George W. Bush.
These days he’s the founder and CEO of the Hargan Group, where he focuses on health care, government relations and public affairs.
Joe Grogan [not the podcaster!]
Joe Grogan served as an assistant to Trump and director of his Domestic Policy Council. He also was a member of the White House Coronavirus Task Force in the early days of the pandemic. But Grogan didn’t stay in the administration the entirety of the first term and resigned in May 2020 to join Verde Technologies.During his time in the White House, Grogan worked closely on efforts to lower drug costs, ban surprise medical bills and expand COVID-19 testing. He’s been a vocal opponent of the Biden administration’s policies to have Medicare negotiate drug costs, saying it would lead to less pharmaceutical innovation, and has repeatedly called for FDA reform to speed up the drug review and approval process.
These days Grogan is also at Paragon Health Institute where he serves as chairman of the board.
Bobby Jindal
The former Louisiana governor is now chair of the Center for a Healthy America, a wing of the America First Policy Institute, a conservative think tank advising Trump. Jindal’s focus on health policy isn’t new: he served as HHS assistant secretary under George W. Bush. Over the last few years he’s called for changes to the health care exchanges, increased price transparency measures and advocated against single-payer health care.
Robert F. Kennedy, Jr. is not the only Trump nominee catching flack. The smart, prescient Dr. Jay Bhattacharya is also catching slings and arrows from envious nonentities:
Pandemic Hawks Circle Dr. Jay: Pundits Launch Attacks on Bhattacharya Ahead of his Confirmation HearingsBy Jonathan Turley - December 29, 2024
For those who opposed the censorship and cancel campaigns during the pandemic, Dr. Jay Bhattacharya became an iconic figure of resistance. Unfortunately, the same can be said of the anti-free speech movement and pandemic hawks. Bhattacharya, who co-authored the Great Barrington Declaration and was a vocal critic of COVID-19 policies, has been nominated as the next head of the National Institutes of Health. As I wrote this weekend in my column, the nomination was heralded by many as a turning point for the NIH. It is also a rallying cry for those who supported the earlier measures, as shown by a hit piece in Scientific American, accusing him of being a danger to the very lives of American citizens.
Bhattacharya was censored, blacklisted, and vilified for the last four years due to his opposing views on health policy, including opposing wholesale shutdowns of schools and businesses. He was recently honored with the prestigious “Intellectual Freedom” award from the American Academy of Sciences and Letters.
Before the pandemic, Bhattacharya was one of the most respected scientists in the world and served as the director of Stanford’s Center for Demography and Economics of Health and Aging.
That all changed when he dared to question the science behind pandemic policies, including suggesting that natural immunity would be as good if not better protection for young healthy individuals.
It did not matter that positions once denounced as “conspiracy theories” have been recognized or embraced by many.
Some argued that there was no need to shut down schools, which has led to a crisis in mental illness among the young and the loss of critical years of education. Other nations heeded such advice with more limited shutdowns (including keeping schools open) and did not experience our losses.
Others argued that the virus’s origin was likely the Chinese research lab in Wuhan. That position was denounced by the Washington Post as a “debunked” coronavirus “conspiracy theory.” The New York Times Science and Health reporter Apoorva Mandavilli called any mention of the lab theory “racist.”
Federal agencies now support the lab theory as the most likely based on the scientific evidence.
Likewise, many questioned the efficacy of those blue surgical masks and supported natural immunity to the virus — both positions were later recognized by the government.
Others questioned the six-foot rule, which shut down many businesses, as unsupported by science. In congressional testimony, Dr. Anthony Fauci recently admitted that the rule “sort of just appeared” and “wasn’t based on data.” Yet not only did it result in heavily enforced rules (and meltdowns) in public areas, but the media further ostracized dissenting critics.
Again, Fauci and other scientists did little to stand up for these scientists or call for free speech to be protected. As I discuss in my new book, “The Indispensable Right,” the result is that we never really had a national debate on many of these issues and the result of massive social and economic costs.
Now, those who supported these policies are gathering to oppose Bhattacharya.
It is hardly surprising that one of the first hit pieces came from Scientific American. The magazine not only helped lead the mob response to the pandemic but has also been criticized for abandoning neutrality in recent elections.
Only a few weeks ago, editor-in-chief Laura Helmuth posted a raving, profanity-laden meltdown on social media in which she effectively called over 77.3 million Americans who voted for President-elect Donald Trump both “fascists” and bigots.
Now the magazine has published an article by Dr. Steven Albert, a professor and the Hallen Chair of Community Health and Social Justice at the University of Pittsburgh’s School of Public Health.
Two specific attacks stand out in the piece.
The “Personal Pique” of Censorship
First, Dr. Albert suggests that Dr. Bhattacharya was never actually censored. He insists that what Bhattacharya calls censorship was merely the fact that “social media venues … dropped his messaging.” It is curious wording and it is not quite clear what Dr. Albert is trying to say.
When Albert’s article appeared, various other outlets advanced the same claim. For example, MSNBC (which also was a leading outlet in the attacks on skeptics and dissenters during the pandemic) mocked the claim that Bhattacharya was censored.
“The problem is there’s basically zero evidence to support Bhattacharya and his supporters’ claims of censorship. It is true that some internet sites appeared to remove or limit access to the document. But, as with medical professionals not being sure how best to handle Covid, the same was true of social media companies, which struggled with how best to handle the spread of potentially dangerous information that could have resulted in harm to users.
Many companies chose, of their own free will and as they were allowed as private actors, to downplay certain information that they felt might do more harm than good. That is their own First Amendment-protected right as private entities in the United States.”
The article goes on to suggest that there is no proof of censorship without government direction or control.
As the ACLU has long maintained, censorship occurs in both private and governmental forums. The same figures insist that, if there is no violation of the First Amendment (which only applies to the government), there is no free speech violation. The First Amendment was never the exclusive definition of free speech. Free speech is viewed by many of us as a human right; the First Amendment only deals with one source for limiting it. Free speech can be undermined by private corporations as well as government agencies.
There is also ample evidence of government officials pushing social media companies to censor pandemic critics. MSNBC simply excuses the censorship by saying that these companies “struggled with how best to handle the spread of potentially dangerous information that could have resulted in harm to users.” In reality, the censorship itself cost the nation greatly. We never had the type of debate that we need on the efficacy of natural immunities, masks, or other precautions. We never explored the science supporting the six-foot rule. We suffered immense costs in education and the economy rather than allowing scientists on both sides to be heard equally on such forums.
Instead, Bhattacharya became a persona non grata in academia and was subjected to cancel campaigns. In the Los Angeles Times, columnist Michael Hiltzik decried how “we’re living in an upside-down world” because Stanford allowed these scientists to speak at a scientific forum. He was outraged that, while “Bhattacharya’s name doesn’t appear in the event announcement,” he was an event organizer. Hiltzik also wrote a column titled “The COVID lab leak claim isn’t just an attack on science, but a threat to public health.”
Critics of Bhattacharya have also cited the fact that he retained his position, unlike some who were dropped by their institutions or associations. Survival is hardly the test of whether someone was censored or canceled. Bhattacharya holds a position with academic protections, as do some of us fortunate to have tenure in this age of rage. The fact that he persisted and the American people rejected the establishment in this election is not proof that he was not targeted or blocked from academic settings or social media sites.
Dr. Albert dismisses the censorship debate as a “personal pique” and “a distraction” that “should not obscure the central focus of U.S. public health policy during the pandemic.” Obviously, for many of us who value free speech and a diversity of viewpoints, it is a bit more than a “personal pique.”
The “Vanity” of Personal Autonomy
The second point that stood out in the Scientific American article was the warning that Bhattacharya is too focused on individual rights and personal autonomy to be the head of NIH. Dr. Albert declares:
“Pitting personal autonomy against the application of science to policy is fine for vanity webcasts and think tanks, but inappropriate for NIH leadership. If he would rather focus on promoting personal autonomy in pandemic policy, perhaps he is being nominated to the wrong agency.”
It is a chilling observation from a leading public health figure. NIH leadership suggests policies impacting a nation and must balance the costs and benefits of any given course. The NIH states that it is focused not just on “scientific integrity” but “public accountability and social responsibility in the conduct of science.” Isn’t individual rights part of that responsibility?
I would hope that the head of NIH (indeed every NIH official) would place individual rights and personal autonomy as one of the most prominent considerations in setting policies.policy-making Indeed, the NIH routinely discusses and publishes papers on the importance of personal autonomy when discussing subjects like abortion.
These two points are linked on some level. The nation was divided on many COVID policies, and doubts only grew with the censorship and intolerance that was evident during the pandemic. The NIH contributed to that mistrust with its heavy-handed tactics and viewpoint intolerance. One of the victims of that period will now head the NIH. That experience could be invaluable as Dr. Bhattacharya steers his agency toward a more transparent and tolerant path.
Jonathan Turley is the Shapiro professor of public interest law at George Washington University.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















